News of Note—Altimmune, Ebola outbreak and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> Altimmune CEO Bill Enright plans to step down from his post early next year, or when a successor is appointed. Washington Business Journal article

> Teams fighting the Ebola outbreak are struggling to find potential vaccine recipients. Stat News article

> Seqirus' Afluria Quadrivalent won a label expansion in the U.S. It's now approved for people 6 months and older. Release

Read more on

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.